Clinical Trial Update: Electromechanical Mapping to Evaluate Heart Muscle [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating electromechanical mapping to assess heart muscle in myocardial ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myocardial Ischemia | Phase 3 | Status: COMPLETED